SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lisa Eidenschink Brodersen, Andrew J. Menssen, Jamie R. Wangen, Christine F. Stephenson, Monica E. de Baca, Barbara K. Zehentner, Denise A. Wells, Michael R. Loken, Assessment of erythroid dysplasia by “Difference from normal” in routine clinical flow cytometry workup, Cytometry Part B: Clinical Cytometry, 2015, 88, 2
  2. 2
    Frauke Bellos, Wolfgang Kern, Flow cytometry in the diagnosis of myelodysplastic syndromes and the value of myeloid nuclear differentiation antigen, Cytometry Part B: Clinical Cytometry, 2015, 88, 4
  3. 3
    Eline M.P. Cremers, Canan Alhan, Theresia M. Westers, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Immunophenotyping for diagnosis and prognosis in MDS: Ready for general application?, Best Practice & Research Clinical Haematology, 2015, 28, 1, 14

    CrossRef

  4. 4
    Suiellen C Reis-Alves, Fabiola Traina, Konradin Metze, Irene Lorand-Metze, Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors, Diagnostic Pathology, 2015, 10, 1

    CrossRef

  5. 5
    Anna Porwit, Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?, Current Hematologic Malignancy Reports, 2015,

    CrossRef

  6. 6
    Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger, Torsten Haferlach, Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients, Cytometry Part B: Clinical Cytometry, 2015, 88, 3
  7. 7
    J. R. Wangen, L. Eidenschink Brodersen, T. T. Stolk, D. A. Wells, M. R. Loken, Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation, International Journal of Laboratory Hematology, 2014, 36, 2
  8. 8
    Canan Alhan, Theresia M. Westers, Eline M. P. Cremers, Claudia Cali, Birgit I. Witte, Gert J. Ossenkoppele, Arjan A. Loosdrecht, High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes, British Journal of Haematology, 2014, 167, 1
  9. 9
    Anne S. Roug, Hanne Ø. Larsen, Line Nederby, Tom Just, Gordon Brown, Charlotte G. Nyvold, Hans B. Ommen, Peter Hokland, hMICL and CD123 in combination with a CD45/CD34/CD117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia, British Journal of Haematology, 2014, 164, 2
  10. You have free access to this content10
    Antoine Cottard, Orianne Wagner-Ballon, Jerome Priol, Imane Azzaoui, Beatrice Ly-Sunarram, Thierry Fest, Mikael Roussel, Improvement of the leukocyte differential performed by flow cytometry using the advanced 2.0 version of the CytoDiff CXP software, Cytometry Part A, 2014, 85, 8
  11. 11
    Ulrike Bacher, Torsten Haferlach, Susanne Schnittger, Melanie Zenger, Manja Meggendorfer, Sabine Jeromin, Andreas Roller, Vera Grossmann, Maria-Theresa Krauth, Tamara Alpermann, Wolfgang Kern, Claudia Haferlach, Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact, British Journal of Haematology, 2014, 164, 6
  12. 12
    A Porwit, A A van de Loosdrecht, P Bettelheim, L Eidenschink Brodersen, K Burbury, E Cremers, M G Della Porta, R Ireland, U Johansson, S Matarraz, K Ogata, A Orfao, F Preijers, K Psarra, D Subirá, P Valent, V H J van der Velden, D Wells, T M Westers, W Kern, M C Béné, Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS, Leukemia, 2014, 28, 9, 1793

    CrossRef

  13. 13
    Kate L. Burbury, David A. Westerman, Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment, Leukemia & Lymphoma, 2014, 55, 4, 749

    CrossRef

  14. 14
    Wolfgang Kern, Ulrike Bacher, Susanne Schnittger, Tamara Alpermann, Claudia Haferlach, Torsten Haferlach, Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms, Cytometry Part B: Clinical Cytometry, 2013, 84B, 3
  15. 15
    Arjan A. van de Loosdrecht, Robin Ireland, Wolfgang Kern, Matteo G. Della Porta, Canan Alhan, Jan Sebastian Balleisen, Peter Bettelheim, David T. Bowen, Kate Burbury, Lisa Eidenschink, Mario Cazzola, Spencer S. C. Chu, Matthew Cullen, Jevon A. Cutler, Angelika M. Dräger, Jean Feuillard, Pierre Fenaux, Patricia Font, Ulrich Germing, Detlef Haase, Eva Hellström-Lindberg, Ulrika Johansson, Shahram Kordasti, Michael R. Loken, Luca Malcovati, Jeroen G. te Marvelde, Sergio Matarraz, Timothy Milne, Bijan Moshaver, Ghulam J. Mufti, Veselka Nikolova, Kiyoyuki Ogata, Uta Oelschlaegel, Alberto Orfao, Gert J. Ossenkoppele, Anna Porwit, Uwe Platzbecker, Frank Preijers, Katherina Psarra, Stephen J. Richards, Dolores Subirá, John F. Seymour, Vicky Tindell, Teresa Vallespi, Peter Valent, Vincent H. J. van der Velden, Denise A. Wells, Theo M. de Witte, Florian Zettl, Marie C. Béné, Theresia M. Westers, Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group, Leukemia & Lymphoma, 2013, 54, 3, 472

    CrossRef

  16. 16
    Danielle Marshall, Gail J. Roboz, Standardizing the Initial Evaluation for Myelodysplastic Syndromes, Current Hematologic Malignancy Reports, 2013, 8, 4, 361

    CrossRef

  17. 17
    Faramarz Naeim, P. Nagesh Rao, Sophie X. Song, Wayne W. Grody, Atlas of Hematopathology, 2013,

    CrossRef

  18. 18
    Sara A. Monaghan, Urvashi Surti, Ketah Doty, Fiona E. Craig, Altered neutrophil maturation patterns that limit identification of myelodysplastic syndromes, Cytometry Part B: Clinical Cytometry, 2012, 82B, 4
  19. 19
    Kiyoyuki Ogata, Keiji Kakumoto, Akira Matsuda, Kaoru Tohyama, Hideto Tamura, Yasunori Ueda, Mineo Kurokawa, Jin Takeuchi, Hirohiko Shibayama, Nobuhiko Emi, Toshiko Motoji, Yoshihide Miyazaki, Hiroya Tamaki, Kinuko Mitani, Tomoki Naoe, Haruo Sugiyama, Fumimaro Takaku, Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study, Leukemia Research, 2012, 36, 10, 1229

    CrossRef

  20. 20
    Frauke Bellos, Tamara Alpermann, Elena Gouberman, Claudia Haferlach, Susanne Schnittger, Torsten Haferlach, Wolfgang Kern, Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients, Cytometry Part B: Clinical Cytometry, 2012, 82B, 5
  21. 21
    Theresia M. Westers, Vincent H.J. van der Velden, Canan Alhan, Roelof Bekkema, André Bijkerk, Rik A. Brooimans, Claudia Cali, Angelika M. Dräger, Valerie de Haas, Christa Homburg, Anja de Jong, P. (Ellen) A. Kuiper-Kramer, Marije Leenders, Ingrid Lommerse, Jeroen G. te Marvelde, Joke K. van der Molen-Sinke, Bijan Moshaver, Andre B. Mulder, Frank W.M.B. Preijers, Roger K. Schindhelm, Alita van der Sluijs, Elisabeth R. van Wering, August H. Westra, Arjan A. van de Loosdrecht, Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS, Leukemia Research, 2012, 36, 4, 422

    CrossRef

  22. 22
    Torsten Haferlach, Molecular genetics in myelodysplastic syndromes, Leukemia Research, 2012, 36, 12, 1459

    CrossRef

  23. 23
    Guilin Tang, Jeffrey L. Jorgensen, Yi Zhou, Ying Hu, Marian Kersh, Guillermo Garcia-Manero, L. Jeffrey Medeiros, Sa A. Wang, Multi-color CD34+ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia, Leukemia Research, 2012, 36, 8, 974

    CrossRef

  24. 24
    T M Westers, R Ireland, W Kern, C Alhan, J S Balleisen, P Bettelheim, K Burbury, M Cullen, J A Cutler, M G Della Porta, A M Dräger, J Feuillard, P Font, U Germing, D Haase, U Johansson, S Kordasti, M R Loken, L Malcovati, J G te Marvelde, S Matarraz, T Milne, B Moshaver, G J Mufti, K Ogata, A Orfao, A Porwit, K Psarra, S J Richards, D Subirá, V Tindell, T Vallespi, P Valent, V H J van der Velden, T M de Witte, D A Wells, F Zettl, M C Béné, A A van de Loosdrecht, Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group, Leukemia, 2012, 26, 7, 1730

    CrossRef

  25. 25
    Benjamin Wiench, Tolga Eichhorn, Bernhard Korn, Malte Paulsen, Thomas Efferth, Utilizing inherent fluorescence of therapeutics to analyze real-time uptake and multi-parametric effector kinetics, Methods, 2012, 57, 3, 376

    CrossRef

  26. 26
    Adina M. Cioc, Phuong L. Nguyen, Hematopathology, 2012,

    CrossRef

  27. You have free access to this content27
    Matteo Giovanni Della Porta, Francesco Lanza, Luigi Del Vecchio, Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia, Cytometry Part B: Clinical Cytometry, 2011, 80B, 4
  28. 28
    Arjan A. van de Loosdrecht, Theresia M. Westers, Flow cytometry in myelodysplastic syndromes: Ready for translation into clinical practice, Leukemia Research, 2011, 35, 7, 850

    CrossRef

  29. You have free access to this content29
    Jevon A. Cutler, Denise A. Wells, Arjan A. van de Loosdrecht, Monica E. de Baca, Michael H. Kalnoski, Barbara K. Zehentner, Lisa Eidenschink, Keely M. Ghirardelli, Julie Sanford Biggerstaff, Michael R. Loken, Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias, Cytometry Part B: Clinical Cytometry, 2011, 80B, 3
  30. 30
    Anna Porwit, Role of flow cytometry in diagnostics of myelodysplastic syndromes—beyond the WHO 2008 classification, Seminars in Diagnostic Pathology, 2011, 28, 4, 273

    CrossRef